18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Conditions:   Deep Fibromatosis/Desmoid Tumor;   Familial Adenomatous PolyposisInterventions:   Radiation: F-18 16 Alpha-Fluoroestradiol;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker AnalysisSponsors:   Vanderbilt-Ingram Cancer Center;   National Cancer Institute (NCI)Recruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2015 Category: Research Source Type: clinical trials

Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular Targets
Condition:   Desmoid Type-fibromatosisIntervention:   Drug: ToremifeneSponsors:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano;   Associazione Italiana per la Ricerca sul CancroRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2015 Category: Research Source Type: clinical trials

Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
Condition:   Desmoid-type FibromatosisIntervention:   Other: Observational approachSponsors:   Fondazione IRCCS Istituto Nazionale dei Tumori, Milano;   Ministero della Salute, ItalyRecruiting - verified September 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 28, 2015 Category: Research Source Type: clinical trials

South Miami Hospital Fibroid Registry
Condition:   Uterine Myomas, Leiomyomas, or Fibromas.Intervention:   Sponsor:   Baptist Health South FloridaRecruiting - verified February 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 20, 2015 Category: Research Source Type: clinical trials

Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction
Conditions:   Hernia, Ventral;   Intestinal Fistula;   Fibromatosis, AbdominalInterventions:   Procedure: Abdominal wall reconstruction with Strattice;   Other: Assess pain intensity at last office visit preoperatively;   Other: Assess pain interference at last office visit preoperatively;   Other: Assess physical functioning at last office visit preoperatively;   Other: Assess patient quality of life at last office visit preoperatively;   Other: Assess patient pain intensity postoperatively;   Other: Assess pain interference postoperative...
Source: ClinicalTrials.gov - August 18, 2014 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition:   Deep Fibromatosis/Desmoid TumorInterventions:   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Drug: Sorafenib TosylateSponsor:   National Cancer Institute (NCI)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition:   Desmoid-Type FibromatosisInterventions:   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Drug: Sorafenib TosylateSponsor:   National Cancer Institute (NCI)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition:   Deep Fibromatosis/Desmoid TumorInterventions:   Drug: Sorafenib Tosylate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life AssessmentSponsor:   National Cancer Institute (NCI)Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition:   Desmoid TumorInterventions:   Drug: sorafenib tosylate;   Other: placebo;   Other: laboratory biomarker analysis;   Other: quality-of-life assessmentSponsor:   National Cancer Institute (NCI)Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition:   Desmoid-Type FibromatosisInterventions:   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Drug: Sorafenib TosylateSponsor:   National Cancer Institute (NCI)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition:   Deep Fibromatosis/Desmoid TumorInterventions:   Drug: Sorafenib Tosylate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life AssessmentSponsor:   National Cancer Institute (NCI)Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition:   Desmoid-Type FibromatosisInterventions:   Other: Laboratory Biomarker Analysis;   Other: Placebo;   Other: Quality-of-Life Assessment;   Drug: Sorafenib TosylateSponsor:   National Cancer Institute (NCI)Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials

Sorafenib Tosylate in Treating Patients With Desmoid Tumors or Aggressive Fibromatosis
Condition:   Deep Fibromatosis/Desmoid TumorInterventions:   Drug: Sorafenib Tosylate;   Other: Placebo;   Other: Laboratory Biomarker Analysis;   Other: Quality-of-Life AssessmentSponsor:   National Cancer Institute (NCI)Recruiting - verified September 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 17, 2014 Category: Research Source Type: clinical trials